Samantha Kelly

Sure.

So this is something that he's kind of hinted at before, but this is the first time he's really outlined perhaps in the next two years.

He pointed to the fact that the company is pretty much a standalone business at this point, has hardware, software, has accessories, apparel, its own proprietary technology.

And he said that it's really gotten to a point where they can move forward and

And, you know, he raised the question, if you think about a big company that really owns the idea of personalized health at the moment in the public space, what comes to mind?

And he said Whoop is the company that he wants people to think of when the time comes.

Absolutely, yeah.

To your point, a lot of companies now are really stepping it up, doing a lot of the same type of features and type of results and data.

But to your point, as far as product roadmap goes, one of the areas that a lot of companies have yet to master is the idea of continuous glucose monitoring.

A lot of these devices, they monitor your glucose levels.

A lot of people with diabetes, this is something that they need to do.

And the technology behind it is quite clunky.

It's very invasive.

It usually involves needles and the puncture in the skin.

A lot of companies want to perhaps change the form factor.

Whoop is one of these companies.

They say that they are interested in not only taking that information and using it as part of its overall dashboard, but also to figure out a new form factor that makes it easier, more seamless, and is non-invasive for users.

Another area is what he calls a health operating system.

So basically something that you can come to and do a little bit of everything.

And similar to how an AI model perhaps might predict the next word if you're using a chat GPT or something like that, OOP has its own AI models.